New drug RBD5044 aims to lower high triglycerides in phase 2 trial
NCT ID NCT07587788
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 2 trial tests whether the drug RBD5044 can safely lower high triglyceride levels in adults. About 40 Chinese participants with high triglycerides will receive either RBD5044 or a placebo twice over 84 days. The main goal is to see if RBD5044 reduces triglyceride levels compared to placebo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
RBD5044
What this could lead to
If it works, this could lead to a new treatment option for people with high triglycerides, helping reduce heart disease risk.
What could go wrong
This is an early Phase 2 trial with only 40 participants, so results may not apply to everyone. The drug may not lower triglycerides better than placebo, and side effects are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Daqing People's Hospital
RECRUITINGDaqing, Heilongjiang, China
Contact
Contact
-
Jingzhou Central Hospital
RECRUITINGJingzhou, Hubei, China
Contact
Contact
-
Lishui Central Hospital
RECRUITINGLishui, Zhejiang, China
Contact
Contact
-
Peking University First Hospital
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The First Affiliated Hospital of Henan University of Science and Technology
RECRUITINGLuoyang, Henan, China
Contact
Contact
-
The First Affiliated Hospital of Nanyang Medical College
RECRUITINGNanyang, Nanyang, China
Contact
Contact
-
The Fourth Hospital of Harbin Medical University
RECRUITINGHarbin, Heilongjiang, China
Contact
Contact
-
Yuncheng Central Hospital
RECRUITINGYuncheng, Shanxi, China
Contact
Contact